Professional Summary »
Specializing In »
Practice Locations »
Referring Physicians »
Specializing In
- Addiction Disorders
- Psychiatric Conditions
Biography
Smita Das, MD, PhD, MPH is Board Certified in Psychiatry, Addiction Psychiatry and Addiction Medicine. Dr. Das studied Chemistry and Statistics at Stanford, completed her Masters in Public Health at Dartmouth College, and then completed her MD/PhD in Community Health at the University of Illinois at Urbana Champaign. She completed psychiatry residency and was chief resident at Stanford followed by an addiction psychiatry fellowship at UCSF. She has over 2 decades of experience in research in healthcare quality and addiction. Dr. Das is chair of the APA Council on Addiction Psychiatry and has been a member for a over a decade. She has been a leader in the Northern California Psychiatric Society since 2012 and is a Past President of the APA District Branch. Prior to her position as Medical Director of Psychiatry at Lyra Health, Dr. Das was Director of Addiction Treatment Services at the Palo Alto VA. In addition to her work at Lyra, Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Associate Professor.
View Full Biography »
Professional Summary
Education & Certifications
- Board Certification: American Board of Preventive Medicine, Addiction Medicine (2020)
- Board Certification: American Board of Psychiatry and Neurology, Addiction Psychiatry (2016)
- Fellowship: UCSF Addiction Psychiatry Fellowship (2016) CA
- Residency: Stanford University Adult Psychiatry Residency (2015) CA
- Board Certified, American Board of Psychiatry & Neurology, Psychiatry (2015)
- MD, University of Illinois at Urbana Champaign (2011)
- PhD, University of Illinois at Urbana Champaign, Community Health (2010)
- MPH, Dartmouth College, Public Health (2005)
- BS, Stanford University, Chemistry, Statistics (2004)
Honors & Awards
- Addiction Fellowship, Substance Abuse and Mental Health Services Administration (2015)
- American Psychiatric Leadership Fellow, American Psychiatric Association (2013)
- Best Scientific Poster, Annual Meeting of the Society of Behavioral Medicine (2003)
- Committee Member of the Year, Northern California Psychiatric Society (2018)
- First place, Oral Vignette Competition, Research Symposium, University of Illinois (2010)
- George Ginsberg MD Fellowship, American Association for Directors of Psychiatric Residency Training (2015)
- Leadership Fellowship, Association of Women Psychiatrists (2014)
- Member, Arnold P. Gold Humanism in Medicine Honor Society (2011)
- Miller Foundation Research Grant, Stanford Psychiatry (2013)
- Miller Paper Award, Stanford Psychiatry and Behavioral Sciences (2015)
- Outstanding Resident Award, Stanford Psychiatry and Behavioral Sciences (2015)
- Outstanding Teacher among those rated as Excellent, University of Illinois (2006)
- Resident Recognition Award, American Psychiatric Association (2014)
- Resident Travel Scholarship, American Academy of Addiction Psychiatry, NIDA Sponsored (2014)
- Ruth Fox Scholarship, American Society of Addiction Medicine (2015)
- Silicon Valley Scholars 20,000 award Recipient, Intel/Noyce Foundation (2000)
- The David and Nancy Morse Scholarship, University of Illinois (2011)
- The David Mortimer Olkon Scholarship in Psychiatry and Neurology, University of Illinois (2011)
- The O’Morchoe Award for Excellence in the Promotion of Learning by Medical Students, University of Illinois (2011)
- William H. Creswell Award for Outstanding Graduate Student, Community Health University of Illinois (2008)
- Young Investigator Award, American Society of Addiction Medicine (2016)
Memberships
- Council Member, Center for Workplace Mental Health’s Advisory Council, American Psychiatric Association Foundation (2023 - Present)
- Appointed Member, AMA Task force on Cannabis (2020 - Present)
- Member and former Ruth Fox Fellow, American Society of Addiction Medicine (2015 - Present)
- Council Member, Council on Addiction Psychiatry, American Psychiatric Association (2014 - Present)
- Councilor, Council on Addictions, American Psychiatric Association (2014 - Present)
- Member, American Academy of Addiction Psychiatry (2014 - Present)
- Member and Leadership Fellow (former), Association of Women Psychiatrists (2014 - Present)
- Scholar, Stanford Society of Physician Scholars (2014 - Present)
- Secretary, Northern California Psychiatric Society (APA District Branch) (2014 - 2016)
- Member, Leadership Fellow, SAMHSA fellow, American Psychiatric Association (2013 - 2016)
Administrative Appointments
- Chair, Council on Addiction Psychiatry, American Psychiatric Association (2021 - Present)
- President Elect, President, Immediate Past President, Northern California Psychiatric Society, American Psychiatric Association District Branch (2018 - 2021)
Publications
-
Dissemination of an effective inpatient tobacco use cessation program
Taylor, C. B., Miller, N. H., Cameron, R. P., Fagans, E. W., & Das, S. (2005). Dissemination of an effective inpatient tobacco use cessation program. NICOTINE & TOBACCO RESEARCH, 7(1), 129–137. -
Application of an algorithm-driven protocol to simultaneously provide universal and targeted prevention programs
Luce, K. H., Osborne, M. I., Winzelberg, A. J., Das, S., Abascal, L. B., Celio, A. A., … Taylor, C. B. (2005). Application of an algorithm-driven protocol to simultaneously provide universal and targeted prevention programs. INTERNATIONAL JOURNAL OF EATING DISORDERS, 37(3), 220–26. -
Reliability of self-report: paper versus online administration
Luce, K. H., Winzelberg, A. J., Das, S., Osborne, M. I., Bryson, S. W., & Taylor, C. B. (2007). Reliability of self-report: paper versus online administration. COMPUTERS IN HUMAN BEHAVIOR, 23(3), 1384–1389. -
Cytisine, the world's oldest smoking cessation aid.
Prochaska, J. J., Das, S., & Benowitz, N. L. (2013). Cytisine, the world's oldest smoking cessation aid. BMJ (Clinical Research Ed.), 347, f5198-? -
Bus therapy: a problematic practice in psychiatry.
Das, S., Fromont, S. C., & Prochaska, J. J. (2013). Bus therapy: a problematic practice in psychiatry. JAMA Psychiatry , 70(11), 1127–1128. -
Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome
Maldonado, J. R., Sher, Y., Das, S., Hills-Evans, K., Frenklach, A., Lolak, S., … Neri, E. (2015). Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome. ALCOHOL AND ALCOHOLISM, 50(5), 509–18. -
Cytisine, the world’s oldest smoking cessation aid
Prochaska, J. J., Das, S., & Benowitz, N. L. (2013). Cytisine, the world’s oldest smoking cessation aid. British Medical Journal, 347(f5198). -
Infection and the Risk of Topical Anesthetic Induced Clinically Significant Methemoglobinemia after Transesophageal Echocardiography
Vallurupalli, S., Das, S., & Manchanda, S. (2010). Infection and the Risk of Topical Anesthetic Induced Clinically Significant Methemoglobinemia after Transesophageal Echocardiography. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 27(3), 318–323. -
Who pays for poor surgical quality? Building a business case for quality improvement
Dimick, J. B., Weeks, W. B., Karia, R. J., Das, S., & Campbell, D. A. (2006). Who pays for poor surgical quality? Building a business case for quality improvement. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 202(6), 933–937. -
Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope - a meta-analysis.
Vallurupalli, S., & Das, S. (2010). Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope - a meta-analysis. Clinical Pharmacology : Advances and Applications, 2, 163–167. -
Reliability of Self-Report: Paper versus Online Administration
Luce, K. H., Winzelberg, A. J., Das, S., Osborne, M., Bryson, S. W., & Taylor, C. B. (2003). Reliability of Self-Report: Paper versus Online Administration. Computers in Human Behavior, 23(3). -
Smoking & Mental Illness: Strategies to Increase Screening, Assessment & Treatment
Zidonis, D., Das, S., & Tonelli, M. (2015). Smoking & Mental Illness: Strategies to Increase Screening, Assessment & Treatment. The Journal of Lifelong Learning in Psychiatry, 12(3). -
Chapter 144: Tobacco, Smoking and Mental Health
Das, S., & Prochaska, J. J. (2015). Chapter 144: Tobacco, Smoking and Mental Health. Encyclopedia of Mental Health. Elsevier . -
Addiction Training: Striving to Fill an Unmet Need.
Das, S., & Roberts, L. W. (2016). Addiction Training: Striving to Fill an Unmet Need. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry. -
Update on Smoking Cessation: E-Cigarettes, Emerging Tobacco Products Trends, and New Technology-Based Interventions.
Das, S., Tonelli, M., & Ziedonis, D. (2016). Update on Smoking Cessation: E-Cigarettes, Emerging Tobacco Products Trends, and New Technology-Based Interventions. Current Psychiatry Reports, 18(5), 51. -
Smoking Trends Among Adults With Behavioral Health Conditions in Integrated Health Care: A Retrospective Cohort Study.
Young-Wolff, K. C., Kline-Simon, A. H., Das, S., Mordecai, D. J., Miller-Rosales, C., & Weisner, C. (2016). Smoking Trends Among Adults With Behavioral Health Conditions in Integrated Health Care: A Retrospective Cohort Study. Psychiatric Services , 67(9), 996–1003. -
Intravenous Use of Intranasal Naloxone: A Case of Overdose Reversal.
Das, S., Shah, N., & Ghadiali, M. (2016). Intravenous Use of Intranasal Naloxone: A Case of Overdose Reversal. Substance Abuse, 0. -
Smoking, Mental Illness, and Public Health.
Prochaska, J. J., Das, S., & Young-Wolff, K. C. (2016). Smoking, Mental Illness, and Public Health. Annual Review of Public Health. -
Treating Smoking in Adults With Co-occurring Acute Psychiatric and Addictive Disorders.
Das, S., Hickman, N. J., & Prochaska, J. J. (2017). Treating Smoking in Adults With Co-occurring Acute Psychiatric and Addictive Disorders. Journal of Addiction Medicine. -
Tobacco use disorder and treatment: new challenges and opportunities
Ziedonis, D., Das, S., & Larkin, C. (2017). Tobacco use disorder and treatment: new challenges and opportunities. DIALOGUES IN CLINICAL NEUROSCIENCE, 19(3), 271-+. -
Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders.
Das, S., & Prochaska, J. J. (2017). Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders. Expert Review of Respiratory Medicine, 11(10), 841–50. -
E-Cigarettes: Harmful or Harm-Reducing? Evaluation of a Novel Online CME Program for Health Care Providers.
Fielding-Singh, P., Brown-Johnson, C., Oppezzo, M., Das, S., Jackler, R., & Prochaska, J. J. (2019). E-Cigarettes: Harmful or Harm-Reducing? Evaluation of a Novel Online CME Program for Health Care Providers. Journal of General Internal Medicine. -
The CBD Dialectic in Mental Health: Benign and Powerful?
Das, S. (2019). The CBD Dialectic in Mental Health: Benign and Powerful? Psychiatric Services (Washington, D.C.), appips201900394. -
Excessive Spending in a "Free-to-Play" Smartphone Game.
Kleinman, R. A., & Das, S. (2020). Excessive Spending in a "Free-to-Play" Smartphone Game. The American Journal on Addictions. -
Problematic Use of a Smartphone Game Leading to Excessive Spending
Kleinman, R. A., & Das, S. (2020). Problematic Use of a Smartphone Game Leading to Excessive Spending. AMERICAN JOURNAL ON ADDICTIONS, 29(3), 216–17. -
E-Cigarette Use and Perceptions Among Veterans Receiving Outpatient Treatment in Veterans Affairs Substance Use and Mental Health Clinics.
Dixit, D., Herbst, E., & Das, S. (2020). E-Cigarette Use and Perceptions Among Veterans Receiving Outpatient Treatment in Veterans Affairs Substance Use and Mental Health Clinics. Military Medicine. -
Primary Care Is Essential in Screening, Treating, and Referring People for Unhealthy Drug Use.
Weissman-Ward, A., & Das, S. (2021). Primary Care Is Essential in Screening, Treating, and Referring People for Unhealthy Drug Use. American Family Physician, 103(12), 711–712. -
Telemental Health Collaborative Care Medication Management: Implementation and Outcomes
Das, S., Wang, J., Chen, S.-Y., & Chen, C. E. (2021). Telemental Health Collaborative Care Medication Management: Implementation and Outcomes. TELEMEDICINE AND E-HEALTH.
Practice Locations
,
,
Outpatient Psychiatry Clinic ,
,Outpatient Psychiatry Clinic
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology orders
- View referral status
- Access medical records